Daftar Isi
1. AstraZeneca slides after reports of Bristol Myers merger talks leave analysts 'perplexed'
AstraZeneca shares dropped on Monday after reports that the company had discussed a potential mega-merger with
2. The case for — and against — an AZ-BMS megadeal
AstraZeneca and
3. How will BMS’s acquisition of Celgene impact the availability of drugs and services for myeloma pts
In this week's video, Dr. Durie discusses how the acquisition of Celgene Corporation by
4. 2016 WMIF | Fireside Chat: Giovanni Caforio, MD, CEO, Bristol-Myers Squibb
Introduction by: Thomas Lynch, MD, CEO, Mass General Physician's Organization Moderator: Meg Tirrell, Biotech and Pharma ...
5. Dr. Alice Walsh of Bristol-Myers Squibb (BMS) on Translational Medicine
As the head of analytics innovation oncology translational bioinformatics at
6. Bristol Myers Plans to Launch Nine New Drugs, CEO Says
Bristol Myers Squibb
7. The state of pharmaceuticals: Bristol-Myers Squibb's plan to buy RayzeBio
Jared Hopkins, Wall Street Journal, joins 'The Exchange' to discuss
8. We got a number of important drugs from the Celgene acquisition, says Bristol Myers Squibb CEO
Bristol Myers Squibb
9. This is Innovation: Bristol Myers Squibb is building the future of cancer care in Indiana
RayzeBio, a
10. Bristol Myers acquiring Karuna Therapeutics in $14B deal
bristolmyers
11. Three pharma AI supercomputers. All three the largest.
thebiointel.com/?utm_source=youtube&utm_medium=longform&utm_content=description&utm_campaign= ...
12. BMS, NVIDIA to build 'most powerful' AI factory for life sciences #news #pharma
In today's news: 20 July 2026 -
13. Bristol Myers to buy Karuna Therapeutics for $14 billion
CNBC's Joe Kernen reports on the latest news.
14. The Cell Therapy Process (BMS Cell Therapy Manufacturing Tour)
Manufacturing of autologous cell therapies requires a personalized process, with each therapy created from an individual patient's ...
15. Bristol Myers Squibb stock rises following FDA approval of its schizophrenia drug
CNBC's Angelica Peebles joins 'Fast Money' to report on
Cafe Pharma Bms Information Guide
Introduction of Cafe Pharma Bms

Core Information

Developments

Deep Dive
Data is compiled from public records and verified media reports.
Last Updated: August 10, 2026
Final Thoughts

Disclaimer: Disclaimer: All information is compiled from publicly available data, media reports, and analysis. Actual details may vary.










